BTNX Inc.
BTNX – Rapid Response Fentanyl Test Strips
BTNX Inc. has developed Rapid Response Fentanyl Strips, an easy to use fentanyl deteciton strip. BTNX is a biotechnology company and a world leader in rapid, point-of-care diagnostics. We specialize in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests for laboratories, clinics, hospitals and physicians’ offices. BTNX Inc. also develops information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions.
* New Fentanyl Detection Standards Will Protect First Responders in the Field
Fentanyl Forensic Test Strips
BTNX COVID-19 lgG/lgM Test Cassette
Excerpt - The COVID-19 IgG/IgM Rapid Test Device is the first FDA Emergency Use Authorized Rapid, Point-of-Care, CLIA Waived COVID-19 antibody test. This test is used for the detection of anti-SARS-CoV-2 IgM and IgG antibodies in human whole blood, serum, or plasma samples. This test has been authorized for use with fingerstick blood, intended for identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection to the disease. In just 15 minutes, you are able to provide patients & clients actionable information at the Point of Care!
More Information
BTNX Rapid Response Fentanyl Test Strips
Excerpt - The BTNX Rapid Response Fentanyl Test Strips and Fentanyl Forensic Test Kit are a lateral flow Chromatographic Immunoassay for the detection of Fentanyl. It is a qualitative test for liquid and powder substances at the cut-off concentration of 200 ng/mL.
More Information